DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Rini BI, Powles T, Atkins MB. , et al; IMmotion151 Study Group.
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet 2019;
393 (10189): 2404-2415
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.